Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods

about

Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production Mathematical model of adherent Vero cell growth and poliovirus production in animal component free medium.

P2860

Q28066032-B66C289C-36DE-4808-996C-1444430D639D Q41711727-DE1FC179-5D21-4519-B174-C45001509FA9

P2860

Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods

Item

http://www.wikidata.org/entity/Q42234547

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@en

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@nl

type

Item

label

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@en

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@nl

prefLabel

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@en

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@nl

P1476

Improved poliovirus D-antigen ...... Vero cell cultivation methods

@en

P2093

Leo A van der Pol

http://www.w3.org/2001/XMLSchema#string

Olaf Rubingh

http://www.w3.org/2001/XMLSchema#string

René H Wijffels

http://www.w3.org/2001/XMLSchema#string

Wilfried A M Bakker

http://www.w3.org/2001/XMLSchema#string

Yvonne E Thomassen

http://www.w3.org/2001/XMLSchema#string

P2860

Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.

Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.

Development and optimization of an adenovirus production process.

Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.

Cost analysis of post-polio certification immunization policies.

Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.

High-density microcarrier cell cultures for influenza virus production.

Kinetic characterization of vero cell metabolism in a serum-free batch culture process.

Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing.

P304

2782-2788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2014.02.022

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260393859

http://www.w3.org/2001/XMLSchema#string

P698

24583004

http://www.w3.org/2001/XMLSchema#string

P932

5355417

http://www.w3.org/2001/XMLSchema#string

Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods

about

P2860

P2860

Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932